Trial Profile
Study of dabigatran on the activated partial thromboplastin time and activated clotting time in artrial fibrillation patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Dec 2015
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Thrombosis
- Focus Therapeutic Use
- 01 Dec 2015 New trial record